Subarachnoid Block Versus Ultrasound Guided Transversalis Fascia Plane Block for Postoperative Analgesia of Inguinal Hernia Repair in Adults

Cairo University (CU)

Status: Enrolling

Conditions: Postoperative Analgesia of Inguinal Hernia Repair in Adults

Treatments: Drug: bupivacaine injection by ultrasound guided transversalis fascia plane block

Study type: Interventional

Funder types: Other

Identifiers

NCT06219837

(TFP) block

Details and patient eligibility

About

The aim of our study is to investigate the effect of the ultrasound guided transversalis fascia plane block on the postoperative opioid consumption as a part of multimodal analgesia in patients undergoing inguinal herniorrhaphy under spinal anesthesia.

Full description

The aim of our study is to investigate the efficacy of the ultrasound-guided transversalis fascia plane block as a postoperative analgesia as a part of multimodal analgesia in patients undergoing inguinal herniorrhaphy under spinal anesthesia.

The ultrasound (US)-guided transversalis fascia plane (TFP) block was first described by Hebbard in 2009. A local anesthetic (LA) injected between the transversus abdominis muscle, and its deep investing fascia will block the anterior and the lateral branches of the T12 and L1 nerves (4). The efficacy of this block has been demonstrated in iliac crest bone graft harvesting, caesarean section and inguinal herniorrhaphy

Enrollment: 80 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients undergoing inguinal herniorrhaphy.
• Patients 18-60 years.
• ASA I and II.
• Both sexes.
• Having no contraindication for spinal anesthesia or TFP block.

Exclusion criteria

• Refusal of regional anesthesia.
• Infection in the back or at the site of injection for TFP block.
• INR > 1.5.
• Platelet count < 80000 per microliter of blood.
• Patients known to be allergic to amide local anesthetics.
• BMI greater than 35 kgm_2.
• Opioid addiction.
• Have communication problems that may hinder the assessement of pain postoperative.

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

80 participants in 2 patient groups, including a placebo group

bupivacaine group

Active Comparator group

Description:

the patient in this arm will receive 20 ml of 0.25% bupivacaine injection by ultrasound guided transversalis fascia block for inguinal herniorraphy

Treatment:

Drug: bupivacaine injection by ultrasound guided transversalis fascia plane block

20 ml of 0.9% normal saline solution

Placebo Comparator group

Description:

he patient in this arm will receive 20 ml of 0.9% normal saline solution by ultrasound guided transversalis fascia block for inguinal herniorraphy

Treatment:

Drug: bupivacaine injection by ultrasound guided transversalis fascia plane block